1. Açık Erişim@BUU
  2. İndeksli Yayınlar
  3. Web of Science
Please use this identifier to cite or link to this item: http://hdl.handle.net/11452/28415
Full metadata record
DC FieldValueLanguage
dc.date.accessioned2022-09-01T07:58:16Z-
dc.date.available2022-09-01T07:58:16Z-
dc.date.issued2004-12-
dc.identifier.citationNak, D. vd. (2004). “Treatment of feline mammary fibroadenomatous hyperplasia with aglepristone”. Australian Veterinary Practitioner, 34(4), 161-162.en_US
dc.identifier.issn0310-138X-
dc.identifier.urihttp://hdl.handle.net/11452/28415-
dc.description.abstractA case of fibroadenomatous hyperplasia of the mammary gland in a nine-month-old female cat is reported. It was treated with medroxyprogesterone acetate for the suppression of oestrus. Two weeks later. hyperplasia occurred in all mammary glands. The progesterone receptor blocker aglepristone was given sc (10mg/kg) on days 1, 2 and 7. Mammary gland hyperplasia had completely regressed by day 21.en_US
dc.language.isoenen_US
dc.publisherAustralian Small Animal Veterinary Assocen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectVeterinary sciencesen_US
dc.subjectFelidaeen_US
dc.subjectFelis catusen_US
dc.titleTreatment of feline mammary fibroadenomatous hyperplasia with aglepristoneen_US
dc.typeEditorial Materialen_US
dc.identifier.wos000226461600005tr_TR
dc.identifier.scopus2-s2.0-13444256138tr_TR
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.contributor.departmentUludağ Üniversitesi/Veteriner Fakültesi/Doğum ve Ji̇nekoloji̇ Anabi̇li̇m Dalı.tr_TR
dc.identifier.startpage161tr_TR
dc.identifier.endpage162tr_TR
dc.identifier.volume34tr_TR
dc.identifier.issue4tr_TR
dc.relation.journalAustralian Veterinary Practitioneren_US
dc.contributor.buuauthorNak, Deniz-
dc.contributor.buuauthorNak, Yavuz-
dc.contributor.buuauthorSeyrek, Kamil İntaş-
dc.contributor.buuauthorKumru, İsmail Hakkı-
dc.contributor.researcheridAAH-7292-2019tr_TR
dc.contributor.researcheridAAH-5494-2021tr_TR
dc.subject.wosVeterinary sciencesen_US
dc.indexed.wosSCIEen_US
dc.indexed.scopusScopusen_US
dc.wos.quartileQ4en_US
dc.contributor.scopusid9280090000tr_TR
dc.contributor.scopusid8615464000tr_TR
dc.contributor.scopusid6603409870tr_TR
dc.contributor.scopusid16637505700tr_TR
dc.subject.scopusBreast Tumor; Experimental Mammary Neoplasms; Breast Neoplasmsen_US
dc.subject.emtreeArticleen_US
dc.subject.emtreeBreast fibroadenomaen_US
dc.subject.emtreeCaten_US
dc.subject.emtreeControlled studyen_US
dc.subject.emtreeEstrusen_US
dc.subject.emtreeFemaleen_US
dc.subject.emtreeNonhumanen_US
dc.subject.emtreeTime series analysisen_US
dc.subject.emtreeTreatment outcomeen_US
dc.subject.emtreeTumor regressionen_US
dc.subject.emtreeAglepristoneen_US
dc.subject.emtreeAntigestagenen_US
dc.subject.emtreeMedroxyprogesterone acetateen_US
dc.subject.emtreeUnclassified drugen_US
Appears in Collections:Scopus
Web of Science

Files in This Item:
There are no files associated with this item.
Show simple item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.